Skip to main content

Instadose Pharma Corp. (OTC: INSD) Investor Files Securities Class Action Lawsuit 12/30/2021

  • If you purchased a significant amount of shares of Instadose Pharma Corp. (OTC: INSD) between December 8, 2020 and November 24, 2021, and / or if you purchased any OTC: INSD shares prior to December 2020 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: February 28, 2022. OTC: INSD investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

August 2, 2023 - The court issued an order granting the motion for class certification. February 28, 2023 - A motion was filed for class certification. August 25, 2022 - The court clerk made an entry of default on the docket as to both defendants.  August 24, 2022 - A request for entry of default against the defendants for failure to appear or respond in a timely manner to the complai...

You must register (for free) or login to view the entire case.